Literature DB >> 11220409

Ventilator-associated pneumonia: incidence, risk factors, and microbiology.

T T Bauer1, R Ferrer, J Angrill, G Schultze-Werninghaus, A Torres.   

Abstract

Ventilator-associated pneumonia (VAP) is a pulmonary infection that occurs after at least 48 hours of mechanical ventilation (MV). The incidence depends on several factors, although the most important are those related to the host and duration of MV. VAP can be differentiated into early-onset (<5 days) and late-onset types (> or =5 days). The overall incidence of VAP varies between 9% and 70% (average, 20% to 25%), and the majority of episodes occur within the first 5 days. Risk factors for VAP include prolonged MV, older age, supine body position, and type of comorbidity. Oropharyngeal colonization appears to be a risk factor for early-onset pneumonia, whereas prolonged MV and antibiotic pretreatment, especially with broad-spectrum drugs, increase the risk for late-onset VAP Microaspiration of colonized oropharyngeal secretions is a major cause of early-onset VAP, most frequently caused by community-type pathogens. After 5 days of MV, pathological colonization with gram-negative bacteria may occur, and late-onset VAP is more likely to be attributable to this group of microorganism. Incidence, risk factors, and microbiology depend strongly on the time frame in which the episode develops. However, initial and pathological colonization during the intensive care unit stay can modify this concept.

Entities:  

Mesh:

Year:  2000        PMID: 11220409     DOI: 10.1053/srin.2000.20938

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  11 in total

1.  Severe pneumonia in the elderly: a multivariate analysis of risk factors.

Authors:  Wei Li; Cheng Ding; Shaojun Yin
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  A comparative study of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation (IPPV) in patients with flail chest.

Authors:  M Gunduz; H Unlugenc; M Ozalevli; K Inanoglu; H Akman
Journal:  Emerg Med J       Date:  2005-05       Impact factor: 2.740

3.  TLR3 absence confers increased survival with improved macrophage activity against pneumonia.

Authors:  Madathilparambil V Suresh; Vladislav A Dolgachev; Boya Zhang; Sanjay Balijepalli; Samantha Swamy; Jashitha Mooliyil; Georgia Kralovich; Bivin Thomas; David Machado-Aranda; Monita Karmakar; Sanjeev Lalwani; Arulselvi Subramanian; Arun Anantharam; Bethany B Moore; Krishnan Raghavendran
Journal:  JCI Insight       Date:  2019-12-05

4.  Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury.

Authors:  Shane Patman; Sue Jenkins; Kathy Stiller
Journal:  Intensive Care Med       Date:  2008-09-24       Impact factor: 17.440

5.  In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.

Authors:  Carolyn L Cannon; Lisa A Hogue; Ravy K Vajravelu; George H Capps; Aida Ibricevic; Khadijah M Hindi; Aysegul Kascatan-Nebioglu; Michael J Walter; Steven L Brody; Wiley J Youngs
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

6.  Ventilator-Associated Pneumonia: Incidence, Risk Factors and Outcome in Paediatric Intensive Care Units at Cairo University Hospital.

Authors:  Yasmine S Galal; Meray Rene L Youssef; Sally K Ibrahiem
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Chlorhexidine, toothbrushing, and preventing ventilator-associated pneumonia in critically ill adults.

Authors:  Cindy L Munro; Mary Jo Grap; Deborah J Jones; Donna K McClish; Curtis N Sessler
Journal:  Am J Crit Care       Date:  2009-09       Impact factor: 2.228

8.  The tracheal tube: gateway to ventilator-associated pneumonia.

Authors:  Parjam S Zolfaghari; Duncan L A Wyncoll
Journal:  Crit Care       Date:  2011-09-29       Impact factor: 9.097

9.  Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia.

Authors:  Boya Zhang; Samantha Swamy; Sanjay Balijepalli; Sreehari Panicker; Jashitha Mooliyil; Matthew A Sherman; Jaakko Parkkinen; Krishnan Raghavendran; Madathilparambil V Suresh
Journal:  FASEB J       Date:  2019-09-17       Impact factor: 5.834

10.  Pulmonary infections in ICU patients without underlying disease on ventilators.

Authors:  Reza Ghanbarpour; Masoud Saghafinia; Mahdi Ramezani Binabaj; Seyed Jallal Madani; Davood Tadressi; Mohammad Javad Forozanmehr
Journal:  Trauma Mon       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.